verseautx.com

Verseau Therapeutics

Verseau Therapeutics's email is info@verseautx.com .

Verseau is creating a new class of therapeutics, macrophage checkpoint modulators, to benefit patients with cancer, immune and inflammatory diseases. The company's modulators identify novel targets and develop therapies that shift macrophages between immune activators and silencers in disease, enabling physicians to benefit patients from immunotherapy.
View Top Employees for Verseau Therapeutics
img Website verseautx.com
img Industry Biotechnology
img Location Bedford, Massachusetts, United States
img Employees 22
img Founded 2017
img HQ 47 Wiggins Ave
img Email info@verseautx.com
img Funding 54,300,000 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website verseautx.com
img Industry Biotechnology
img Location Bedford, Massachusetts, United States
img Employees 22
img Founded 2017
img LinkedIn linkedin.com/company/verseautx
img HQ 47 Wiggins Ave
img Email info@verseautx.com
img Funding 54,300,000 USD

Top Verseau Therapeutics Employees